Wegovy was made readily available in Europe’s most obese country on Sept. 4, in what Novo called a “controlled and confined launch”. The Norwegian Medicines Agency stated in January 2023 it would not subsidise the drug, saying the price would be also superior in relation into the documented wellness consequences. https://shigesator368djq0.worldblogged.com/profile